TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36368427

Group type: EXPERIMENTAL
Intervention: Baroque music (BM)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Classical music (CM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Comparison of perceived pain
Number of subjects: 26
Study: 33639833

Group type: EXPERIMENTAL
Intervention: PATINA algorithm and decision support tool
Number of subjects: 6500
Study: 32321551

Group type: EXPERIMENTAL
Intervention: Statin plus fenofibrate (rosuvastatin 10 mg plus fenofibrate 160 mg/day)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Statin alone (rosuvastatin 10 mg/day)
Number of subjects: 106
Study: 34587231

Group type: EXPERIMENTAL
Intervention: Higher insulin concentration 30 min after a 75-g oral glucose load (insulin-30)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Greater HOMA-IR
Number of subjects: 243

Group type: COMPARATOR
Intervention: Results from FS2
Number of subjects: 243
Study: 32684106

Group type: EXPERIMENTAL
Intervention: SmartPrompt (SP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unprompted (UP)
Number of subjects: 10
Study: 34565433

Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Mefenamic acid
Number of subjects: 83

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 83
Study: 32587742

Group type: EXPERIMENTAL
Intervention: Communication tool about diet used in public health nurse consultations
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard consultations
Number of subjects: 250
Study: 36265371

Group type: EXPERIMENTAL
Intervention: Nurse-led eHealth cardiac rehabilitation (CR) program
Number of subjects: 20
Study: 32912741

Group type: EXPERIMENTAL
Intervention: Plasma coated GP lenses
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Increasing diameter of GP lenses (10.1 mm or 10.6 mm)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Uncoated GP lenses (9.6 mm diameter)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: All cohorts (plasma coated and uncoated)
Number of subjects: 233
Study: 32725954

Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup 10 mg/kg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Positive BAL culture
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Negative BAL culture
Number of subjects: 61
Study: 35596935

Group type: EXPERIMENTAL
Intervention: Sildenafil (up to 40mg three times/day)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 69
Study: 33676458

Group type: EXPERIMENTAL
Intervention: Online Food Delivery Services (OFDS)
Number of subjects: 480
Study: 32588134

Group type: EXPERIMENTAL
Intervention: Norepinephrine (NE)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 97
Study: 34837395

Group type: EXPERIMENTAL
Intervention: Negative self-talk (NST)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Positive self-talk
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dissociative group (DG)
Number of subjects: 29
Study: 33484082

Group type: EXPERIMENTAL
Intervention: Tension offloading device applied preoperatively
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tension offloading device applied preoperatively and postoperatively
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12
Study: 34108184

Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 407

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 407
Study: 33275668

Group type: EXPERIMENTAL
Intervention: Novel targeted agents (ibrutinib, acalabrutinib, venetoclax)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy-free frontline treatment approaches
Number of subjects: 0
Study: 36108617

Group type: EXPERIMENTAL
Intervention: Antiparasitic antibiotic treatment in Group A
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 70
Study: 34231475

Group type: EXPERIMENTAL
Intervention: Virtual reality application during colonoscopy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard colonoscopy protocol
Number of subjects: 60
Study: 33380030

Group type: EXPERIMENTAL
Intervention: Coupling delays with two different values in a ring network of six oscillators.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Experimental ring of six bidirectionally coupled Colpitts oscillators with delayed connections via RF cables.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fully connected network of fifty nodes with connections randomly assigned to be either undelayed or delayed.
Number of subjects: 6
Study: 35902351

Group type: EXPERIMENTAL
Intervention: Olezarsen (50 mg every 4 weeks)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 114
Study: 33296258

Group type: EXPERIMENTAL
Intervention: Acupressure treatment (performed two times a week for 4 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 50
Study: 32819444

Group type: EXPERIMENTAL
Intervention: McGrath videolaryngoscope (VL)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pentax Airway Scope (AWS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 35
Study: 35115351

Group type: EXPERIMENTAL
Intervention: Motor control and manual therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: General strength and conditioning (GSC)
Number of subjects: 40
Study: 34615684

Group type: EXPERIMENTAL
Intervention: McGrath MAC videolaryngoscope
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Direct laryngoscopy using the Macintosh laryngoscope
Number of subjects: 1000
Study: 32629682

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 90
Study: 35055807

Group type: EXPERIMENTAL
Intervention: Scaling and root planning (SRP) plus gaseous ozone therapy (GROUP A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard treatment (GROUP B)
Number of subjects: 90
Study: 34551783

Group type: EXPERIMENTAL
Intervention: Formal care during lockdown (20 April 2020 to 15 May 2020)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Informal care during lockdown
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Visiting caregivers during lockdown
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Co-residing caregivers during lockdown
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Home nursing care for PwD living alone during lockdown
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cognitive function impact on home nursing service during lockdown
Number of subjects: 105
Study: 32209621

Group type: EXPERIMENTAL
Intervention: Guided online mindfulness-focused intervention (StudiCare Mindfulness)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 120
Study: 35706482

Group type: EXPERIMENTAL
Intervention: NEVERMIND e-health system (smart shirt and mobile application with lifestyle behavioural advice, mindfulness-based therapy, and cognitive behavioural therapy)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 425
Study: 35489648

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (1mg/kg body weight Enoxaparin, subcutaneously, 12 hourly for seven days)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional treatment for pancreatitis (Control group)
Number of subjects: 140
Study: 33684508

Group type: EXPERIMENTAL
Intervention: Behavioral, lifestyle, and psychological therapy interventions
Number of subjects: 151
Study: 35344461

Group type: EXPERIMENTAL
Intervention: Hypnosis group intervention
Number of subjects: 95

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 95
Study: 32507850

Group type: EXPERIMENTAL
Intervention: Cannabis use (lifetime, yes/no; 42 instrument SNPs; GWAS sample size = 162,082)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Alcohol use (drinks-per-week; 53 instrument SNPs; N = 941,280)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tobacco smoking initiation (yes/no; 156 instrument SNPs; N = 1,232,091)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tobacco smoking heaviness (27 instrument SNPs; N = 337,334)
Number of subjects: 50
Study: 32103747

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) point-of-care testing (POCT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Care as usual without CRP POCT
Number of subjects: 11
Study: 36130048

Group type: EXPERIMENTAL
Intervention: PEG‐rhGH 0.1 mg/kg/week (low-dose group)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: PEG‐rhGH 0.2 mg/kg/week (high-dose group)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 360
Study: 33855369

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermediate/immature desmoplastic reaction
Number of subjects: 0
Study: 33561857

Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 299

Group type: COMPARATOR
Intervention: CERA (Epoetin Beta Pegol)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Daprodustat and CERA
Number of subjects: 299
Study: 32234534

Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 331

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 331
Study: 35138997

Group type: EXPERIMENTAL
Intervention: Stepped collaborative care intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 200
Study: 33111541

Group type: EXPERIMENTAL
Intervention: Live Healthy, Work Healthy (LHWH)
Number of subjects: 359
Study: 34261994

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise training (EX) for 12 weeks, goal of 200 min·wk−1
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise training (EX)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No-exercise control condition (CON)
Number of subjects: 49
Study: 34775146

Group type: EXPERIMENTAL
Intervention: HLA-haploidentical relative bone marrow (Haplo-BM)
Number of subjects: 337

Group type: COMPARATOR
Intervention: 2 umbilical cord blood (UCB) units
Number of subjects: 337

Group type: COMPARATOR
Intervention: Nontrial Haplo-BM
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Haplo-PB transplantation
Number of subjects: 337
Study: 34496277

Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy enhanced with Crisis Response Planning for suicide risk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 0
Study: 35017325

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC; 1200 mg)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Omega 3 fatty acids (4 g)
Number of subjects: 130
Study: 32335056

Group type: EXPERIMENTAL
Intervention: Vivinex XY1 IOL
Number of subjects: 80

Group type: COMPARATOR
Intervention: AcrySof SN60WF IOL
Number of subjects: 80
Study: 34656813

Group type: EXPERIMENTAL
Intervention: Expressive Dissonance (ED)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Expressive Suppression (ES)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control condition (naturally observe)
Number of subjects: 144
Study: 32394024

Group type: EXPERIMENTAL
Intervention: Blue milk
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Barium, white water, and white milk
Number of subjects: 30

Group type: COMPARATOR
Intervention: Blue water
Number of subjects: 30
Study: 32902105

Group type: EXPERIMENTAL
Intervention: FDBA alone + collagen membrane (n = 21)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combined FDBA and AB + collagen membrane (n = 21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Comparison between FDBA and combined group
Number of subjects: 42
Study: 34000049

Group type: EXPERIMENTAL
Intervention: Fezolinetant 180 mg/day
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Fezolinetant 60 mg/day
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Fezolinetant
Number of subjects: 73
Study: 32860331

Group type: EXPERIMENTAL
Intervention: Veliparib plus cisplatin-etoposide (CE)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo plus cisplatin-etoposide (CE)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Overall sample adherence to oral therapy
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Treatment-emergent symptoms
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Clinically significant neurotoxicity
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Neurotoxicity scores
Number of subjects: 128
Study: 33809826

Group type: EXPERIMENTAL
Intervention: Synchronous, telephone-based internal health service models of nutrition care
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Mobile application-based delivery methods
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Novel technology for delivering nutrition care
Number of subjects: 13
Study: 35088722

Group type: EXPERIMENTAL
Intervention: Restorative neurostimulator (ReActiv8)
Number of subjects: 204
Study: 33388067

Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet
Number of subjects: 74

Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 74
Study: 34743361

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abrocitinib
Number of subjects: 0
Study: 33008933

Group type: EXPERIMENTAL
Intervention: Add-on azithromycin (AZM)
Number of subjects: 420
Study: 35684157

Group type: EXPERIMENTAL
Intervention: SAGAT (combination of serine, alanine, glutamate, aspartate, and tyrosine)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 33249630

Group type: EXPERIMENTAL
Intervention: 10 mg HS-10234
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 25 mg HS-10234
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 40 mg HS-10234
Number of subjects: 36

Group type: COMPARATOR
Intervention: 300 mg Tenofovir disoproxil fumarate (TDF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HS-10234
Number of subjects: 36
Study: 36009012

Group type: EXPERIMENTAL
Intervention: Low-energy/fat diet (1200–1500 Kcal/day and 15–20% lipids) + Monacolin K (5 mg) + Astaxanthin (0.1 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-energy/fat diet (1200–1500 Kcal/day and 15–20% lipids)
Number of subjects: 80
Study: 32452817

Group type: EXPERIMENTAL
Intervention: Health Integrator smartphone app with additional telephone coaching
Number of subjects: 112

Group type: COMPARATOR
Intervention: Health Integrator smartphone app without additional telephone coaching
Number of subjects: 112
Study: 32032337

Group type: EXPERIMENTAL
Intervention: Electronic surveillance system without a dedicated rounder
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Electronic surveillance system with a dedicated rounder
Number of subjects: 1032
Study: 32589939

Group type: EXPERIMENTAL
Intervention: Mixed fixation (rigid fixation for anterior fracture and nonrigid fixation for posterior fracture)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Nonrigid fixation for both fractures
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Mixed fixation
Number of subjects: 315

Group type: COMPARATOR
Intervention: Nonrigid fixation
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Mixed fixation and Nonrigid fixation
Number of subjects: 315
Study: 35850974

Group type: EXPERIMENTAL
Intervention: secukinumab 150 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: current smokers
Number of subjects: 0
Study: 33337110

Group type: EXPERIMENTAL
Intervention: High-Volume/low-intensity training (HV)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-Intensity/low-volume training (HI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study: 36007918

Group type: EXPERIMENTAL
Intervention: Nicotine exposure (maternal urine cotinine >5 ng/mL)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Heavy nicotine exposure (>100 ng/mL)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Mild nicotine exposure (5-100 ng/mL)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (nonexposed to nicotine)
Number of subjects: 150
Study: 34349460

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 160
Study: 32035729

Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPT) with a battery of 12 aeroallergens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Assessment of relationship between sensitisation and asthma, rhinitis, or eczema
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of sociodemographic factors and helminthic infection
Number of subjects: 0
Study: 35312440

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 60
Study: 32174360

Group type: EXPERIMENTAL
Intervention: Visual-to-auditory sensory substitution devices (SSDs) using The vOICe; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard dichotic listening test; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 35771346

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (400 kcal and 15 g protein daily, multivitamin tablets thrice weekly for 3 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (100 kcal and 2 g protein daily, placebo tablet thrice weekly for 3 months)
Number of subjects: 80
Study: 32634840

Group type: EXPERIMENTAL
Intervention: ACT-based group intervention
Number of subjects: 25
Study: 36326418

Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard nutrition
Number of subjects: 40
Study: 32005582

Group type: EXPERIMENTAL
Intervention: Self-administered artesunate vaginal inserts (1, 2, or 3 five-day treatment cycles at study weeks 0, 2, and 4)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Self-administered artesunate vaginal inserts
Number of subjects: 28
Study: 35427411

Group type: EXPERIMENTAL
Intervention: ibrutinib-rituximab (IR)
Number of subjects: 529

Group type: COMPARATOR
Intervention: fludarabine, cyclophosphamide, and rituximab (FCR)
Number of subjects: 529
Study: 32648834

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32371553

Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA)
Number of subjects: 2356

Group type: COMPARATOR
Intervention: HPV self‐sampling
Number of subjects: 2356

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 2356
Study: 33436922

Group type: EXPERIMENTAL
Intervention: Saccadic Vector Optokinetic Perimetry (SVOP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard Automated Perimetry (SAP)
Number of subjects: 55
Study: 32116321

Group type: EXPERIMENTAL
Intervention: 3D imaging system
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2D imaging system
Number of subjects: 40
Study: 35343716

Group type: EXPERIMENTAL
Intervention: Guilt condition (induced with guilt using a revised mishap paradigm)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Sadness condition (induced with sadness by watching a video)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Baseline condition (no additional emotion-inducing task)
Number of subjects: 192
Study: 34479543

Group type: EXPERIMENTAL
Intervention: Canagliflozin (100 mg daily)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Glimepiride (starting dose 0.5 mg daily)
Number of subjects: 233
Study: 32258159

Group type: EXPERIMENTAL
Intervention: Combination of muscle energy technique (MET) and ischemic compression technique (ICT) along with conventional intervention
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Muscle energy technique (MET) and conventional intervention (without ICT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 60
Study: 35469230

Group type: EXPERIMENTAL
Intervention: Stereotactic aspiration (n = 26)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Decompressive craniectomy (n = 24)
Number of subjects: 50
Study: 33908058

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis ssp. lactis 420 (B420)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32350180

Group type: EXPERIMENTAL
Intervention: Kombu (Laminaria japonica) intake for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kombu (Laminaria japonica) intake
Number of subjects: 0
Study: 34932832

Group type: EXPERIMENTAL
Intervention: Mindfulness training (8-week duration)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Inactive control
Number of subjects: 57
Study: 33606173

Group type: EXPERIMENTAL
Intervention: Project Prepared
Number of subjects: 397

Group type: COMPARATOR
Intervention: TEEN (control)
Number of subjects: 397
Study: 32327087

Group type: EXPERIMENTAL
Intervention: Very early invasive strategy (EG) with coronary angiography (CA) within 2 hours
Number of subjects: 741

Group type: COMPARATOR
Intervention: Delayed invasive strategy (DG) with coronary angiography (CA) performed 12 to 72 hours after randomization
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Very early invasive strategy (EG)
Number of subjects: 741

Group type: COMPARATOR
Intervention: Delayed invasive strategy (DG)
Number of subjects: 741
Study: 36495690

Group type: EXPERIMENTAL
Intervention: Single session mini-course derived from a guided chat-based intervention
Number of subjects: 525
Study: 33011684

Group type: EXPERIMENTAL
Intervention: Compression sutures combined with intracameral air injection (CSAI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thermokeratoplasty (TKP)
Number of subjects: 20
Study: 33677745

Group type: EXPERIMENTAL
Intervention: 3D virtual reality (VR) headset
Number of subjects: 51

Group type: COMPARATOR
Intervention: Desktop (DT) computer interface
Number of subjects: 51